We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+2.83%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.76B
AUM Growth
+$499M
(+6.9%)
Cap. Flow
+$366M
Cap. Flow
% of AUM
4.71%
Top 10 Holdings %
Top 10 Hldgs %
15.72%
Holding
1,667
New
74
Increased
571
Reduced
929
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$48.8M |
| 2 |
Healthpeak Properties
DOC
|
+$16.2M |
| 3 |
Clorox
CLX
|
+$16.1M |
| 4 |
Brown-Forman Class B
BF.B
|
+$14.4M |
| 5 |
Hormel Foods
HRL
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$36.9M |
| 2 |
Apple
AAPL
|
+$10.8M |
| 3 |
JPMorgan Chase
JPM
|
+$6.74M |
| 4 |
Microsoft
MSFT
|
+$6.53M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$5.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.62% |
| 2 | Technology | 13.27% |
| 3 | Financials | 13.22% |
| 4 | Consumer Staples | 11.59% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Commault Systems
CVLT
$5.85B
| $412K | 0.01% |
9,531
-954
| -9% | -$42.1K |
|
|
CAVM
1052
DELISTED
Cavium, Inc.
CAVM
| $412K | 0.01% |
10,683
+723
| +7% | +$35.8K |
|
1053
Vanda Pharmaceuticals
VNDA
$322M
| $410K | 0.01% |
36,607
-411
| -1% | -$3.98K |
|
|
AMRI
1054
DELISTED
Albany Molecular Research Inc
AMRI
| $408K | 0.01% |
30,366
+413
| +1% | +$6.03K |
|
1055
ATI
ATI
$27.3B
| $407K | 0.01% |
31,957
+12,236
| +62% | +$175K |
|
|
PDCE
1056
DELISTED
PDC Energy, Inc.
PDCE
| $406K | 0.01% |
7,055
+815
| +13% | +$48.4K |
|
|
SCMP
1057
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $405K | 0.01% |
36,954
+369
| +1% | +$4.13K |
|
|
PFPT
1058
DELISTED
Proofpoint, Inc.
PFPT
| $404K | 0.01% |
6,398
+638
| +11% | +$36.5K |
|
|
RWT
1059
Redwood Trust
RWT
$614M
| $403K | 0.01% |
29,189
-3,509
| -11% | -$47.1K |
|
|
OTIC
1060
DELISTED
Otonomy, Inc.
OTIC
| $403K | 0.01% |
25,354
+907
| +4% | +$13.5K |
|
1061
Teradata
TDC
$2.6B
| $402K | 0.01% |
16,030
-29
| -0.2% | -$770 |
|
1062
Gentex
GNTX
$5.07B
| $401K | 0.01% |
25,975
-3,531
| -12% | -$56.1K |
|
|
SPPI
1063
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $401K | 0.01% |
61,073
+1,054
| +2% | +$7.45K |
|
1064
CACI
CACI
$10.6B
| $400K | 0.01% |
4,421
+307
| +7% | +$30.5K |
|
1065
Dycom Industries
DY
$13.2B
| $399K | 0.01% |
4,442
-483
| -10% | -$36.5K |
|
|
AERI
1066
DELISTED
Aerie Pharmaceuticals
AERI
| $399K | 0.01% |
22,695
+669
| +3% | +$10.8K |
|
|
FLIR
1067
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $397K | 0.01% |
12,821
-1,244
| -9% | -$38.8K |
|
|
RPTP
1068
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $397K | 0.01% |
73,962
+1,012
| +1% | +$5.19K |
|
1069
Deckers Outdoor
DECK
$13.4B
| $396K | 0.01% |
41,316
-2,694
| -6% | -$24.9K |
|
1070
EnerSys
ENS
$7.29B
| $393K | 0.01% |
6,613
-106
| -2% | -$6.26K |
|
1071
Littelfuse
LFUS
$10.5B
| $393K | 0.01% |
3,324
-64
| -2% | -$7.45K |
|
1072
ImmunityBio
IBRX
$7.75B
| $392K | 0.01% |
63,063
+2,137
| +4% | +$16.6K |
|
1073
Urban Outfitters
URBN
$5.96B
| $392K | 0.01% |
14,252
-731
| -5% | -$21K |
|
|
ESL
1074
DELISTED
Esterline Technologies
ESL
| $392K | 0.01% |
6,319
-347
| -5% | -$22.7K |
|
|
FNGN
1075
DELISTED
Financial Engines, Inc.
FNGN
| $390K | 0.01% |
15,072
+185
| +1% | +$5.32K |
|
Similar funds
ProShare Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, ProShare Advisors held 1,667 positions worth $7.76B, up 6.9% from $7.26B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $366M of net new capital in Q2 2016, opening 74 new positions and adding to 571 existing holdings. Its largest new stake was S&P Global: 454,450 shares worth $48.7M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $10.8M trimmed.
- ProShare Advisors's largest Q2 2016 buy was S&P Global: 454,450 shares worth $48.7M.
- ProShare Advisors added most to Healthpeak Properties in Q2 2016, an estimated $16.2M increase.
- ProShare Advisors's biggest Q2 2016 reduction was Apple, cutting an estimated $10.8M.
- ProShare Advisors fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $36.9M.
- ProShare Advisors's ten largest holdings make up 16% of its $7.76B portfolio in Q2 2016.
- ProShare Advisors opened 74 new positions and closed 86 in Q2 2016.
- ProShare Advisors's portfolio value rose 6.9% quarter-over-quarter to $7.76B.
Based on ProShare Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.